Marinus Pharmaceuticals Statistics
Total Valuation
MRNS has a market cap or net worth of $18.74 million. The enterprise value is $20.85 million.
| Market Cap | 18.74M |
| Enterprise Value | 20.85M |
Important Dates
The next estimated earnings date is Thursday, December 18, 2025, after market close.
| Earnings Date | Dec 18, 2025 |
| Ex-Dividend Date | Aug 4, 2025 |
Share Statistics
MRNS has 74.93 million shares outstanding. The number of shares has decreased by -0.10% in one year.
| Current Share Class | 74.93M |
| Shares Outstanding | 74.93M |
| Shares Change (YoY) | -0.10% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 77.27% |
| Owned by Institutions (%) | 1.02% |
| Float | 13.56M |
Valuation Ratios
The trailing PE ratio is 34.60.
| PE Ratio | 34.60 |
| Forward PE | n/a |
| PS Ratio | 0.38 |
| Forward PS | 0.66 |
| PB Ratio | 1.34 |
| P/TBV Ratio | 1.34 |
| P/FCF Ratio | 1.62 |
| P/OCF Ratio | 1.58 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.02, with an EV/FCF ratio of 1.80.
| EV / Earnings | 38.87 |
| EV / Sales | 0.42 |
| EV / EBITDA | 9.02 |
| EV / EBIT | 13.54 |
| EV / FCF | 1.80 |
Financial Position
The company has a current ratio of 1.35, with a Debt / Equity ratio of 0.63.
| Current Ratio | 1.35 |
| Quick Ratio | 0.55 |
| Debt / Equity | 0.63 |
| Debt / EBITDA | 3.00 |
| Debt / FCF | 0.76 |
| Interest Coverage | 0.98 |
Financial Efficiency
Return on equity (ROE) is 3.89% and return on invested capital (ROIC) is 4.75%.
| Return on Equity (ROE) | 3.89% |
| Return on Assets (ROA) | 3.70% |
| Return on Invested Capital (ROIC) | 4.75% |
| Return on Capital Employed (ROCE) | 12.50% |
| Revenue Per Employee | $176,846 |
| Profits Per Employee | $1,930 |
| Employee Count | 278 |
| Asset Turnover | 1.35 |
| Inventory Turnover | 2.94 |
Taxes
In the past 12 months, MRNS has paid $1.55 million in taxes.
| Income Tax | 1.55M |
| Effective Tax Rate | 74.25% |
Stock Price Statistics
The stock price has decreased by -94.55% in the last 52 weeks. The beta is 0.40, so MRNS's price volatility has been lower than the market average.
| Beta (5Y) | 0.40 |
| 52-Week Price Change | -94.55% |
| 50-Day Moving Average | 0.43 |
| 200-Day Moving Average | 1.06 |
| Relative Strength Index (RSI) | 70.40 |
| Average Volume (20 Days) | 1,233,258 |
Short Selling Information
The latest short interest is 2.32 million, so 4.21% of the outstanding shares have been sold short.
| Short Interest | 2.32M |
| Short Previous Month | 3.62M |
| Short % of Shares Out | 4.21% |
| Short % of Float | 6.72% |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MRNS had revenue of $49.16 million and earned $536,409 in profits. Earnings per share was $0.01.
| Revenue | 49.16M |
| Gross Profit | 4.03M |
| Operating Income | 2.15M |
| Pretax Income | 2.08M |
| Net Income | 536,409 |
| EBITDA | 2.75M |
| EBIT | 2.15M |
| Earnings Per Share (EPS) | $0.01 |
Balance Sheet
The company has $6.66 million in cash and $8.75 million in debt, giving a net cash position of -$2.09 million or -$0.03 per share.
| Cash & Cash Equivalents | 6.66M |
| Total Debt | 8.75M |
| Net Cash | -2.09M |
| Net Cash Per Share | -$0.03 |
| Equity (Book Value) | 13.94M |
| Book Value Per Share | 0.19 |
| Working Capital | 4.56M |
Cash Flow
In the last 12 months, operating cash flow was $11.83 million and capital expenditures -$256,255, giving a free cash flow of $11.58 million.
| Operating Cash Flow | 11.83M |
| Capital Expenditures | -256,255 |
| Free Cash Flow | 11.58M |
| FCF Per Share | $0.15 |
Margins
Gross margin is 8.20%, with operating and profit margins of 4.38% and 1.09%.
| Gross Margin | 8.20% |
| Operating Margin | 4.38% |
| Pretax Margin | 4.24% |
| Profit Margin | 1.09% |
| EBITDA Margin | 5.60% |
| EBIT Margin | 4.38% |
| FCF Margin | 23.55% |
Dividends & Yields
This stock pays an annual dividend of $0.01, which amounts to a dividend yield of 4.28%.
| Dividend Per Share | $0.01 |
| Dividend Yield | 4.28% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 46.57% |
| Buyback Yield | 0.10% |
| Shareholder Yield | 0.10% |
| Earnings Yield | 2.86% |
| FCF Yield | 61.77% |
Analyst Forecast
The average price target for MRNS is $4.28, which is 678.18% higher than the current price. The consensus rating is "Buy".
| Price Target | $4.28 |
| Price Target Difference | 678.18% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (5Y) | 26.06% |
| EPS Growth Forecast (5Y) | -60.36% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 5, 2023. It was a forward split with a ratio of 1.1.
| Last Split Date | Jun 5, 2023 |
| Split Type | Forward |
| Split Ratio | 1.1 |
Scores
MRNS has an Altman Z-Score of 3.01 and a Piotroski F-Score of 7.
| Altman Z-Score | 3.01 |
| Piotroski F-Score | 7 |